Physician profile
Ryan Tyler Johnson
NPI 1265059042
$4,003.79
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $363 · 2021: $599 · 2022: $1,494 · 2023: $1,420 · 2024: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $791 · Travel and Lodging: $757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.38 |
| Travel and Lodging | $757.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $869.94 | 2023-2024 | Portfolio |
| Orthofix Medical, INC. | $844.49 | 2020-2022 | |
| Stryker Corporation | $835.09 | 2021-2024 | Prostep, Sonopet Iq, Phalinx |
| Medline Industries LP | $216.50 | 2021-2022 | |
| Kci USA, INC. | $205.67 | 2021 | |
| In2bones USA, LLC | $163.21 | 2021-2022 | |
| Bioventus LLC | $161.74 | 2022 | |
| Zimmer Biomet Holdings, INC. | $147.87 | 2020-2021 | |
| Convatec INC. | $125.94 | 2023 | |
| Integra Lifesciences Corporation | $125.07 | 2020 | |
| Linvatec Corporation | $111.50 | 2023 | Colink Plating System, Fracture and Correction Colag 2 |
| Polynovo North America LLC | $90.18 | 2022 | |
| Baudax Bio INC. | $61.10 | 2021 | |
| Kerecis Limited | $31.20 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Hartmann USA, INC. | $14.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.